Cost figures reflect 2025–2026 data; medication prices cite GoodRx retail and coupon rates last updated July 2026, and evaluation and therapy ranges reflect national cash-pay averages that vary by provider, state, and insurance status.
TL;DR — Quick Verdict
- A full ADHD workup for adults spans a wide range: brief screenings start near $150, standard clinical evaluations run $400–$800, and comprehensive neuropsychological testing reaches $2,500–$5,000+.
- Generic stimulants are cheap with a coupon — generic Adderall drops to about $16.99 per month via GoodRx versus a $53.16 retail average, while brand Vyvanse averages $309.44.
- Therapy and behavioral treatment cost $100–$250 per session cash-pay, but in-network insurance typically cuts that to a $20–$50 copay.
- Cash-pay telehealth (Done at $299 + $79/month) versus insurance-based psychiatry (Talkiatry copays of $20–$60) can swing your first-year total by more than $1,000.
- The CDC counts 15.5 million U.S. adults with a current ADHD diagnosis, and 71.5% of those on stimulants reported trouble filling a prescription — budget for both cost and supply gaps.
- Recommendation: match evaluation depth to your actual need, use generics plus a discount card, and verify in-network coverage before your first appointment.
The Centers for Disease Control and Prevention counts 15.5 million U.S. adults — 6.0% of the adult population, or one in 16 — with a current ADHD diagnosis, and more than half were first diagnosed as adults. That surge collides with a blunt financial reality: the price of getting evaluated, treated, and medicated ranges from a couple hundred dollars to well over five thousand, depending on choices most people make blind. A single provider might quote $400 for a clinical interview while a neuropsychology practice down the street quotes $3,500 for testing that overlaps heavily in purpose.
This guide breaks down what each piece actually costs in 2026 — evaluation, therapy, and medication — using CDC prevalence data, GoodRx pharmacy pricing, and published rates from telehealth platforms including Done, Klarity, and Talkiatry. You’ll get real dollar figures, a direct cash-pay-versus-insurance comparison, the mistakes that inflate bills, and a framework for deciding which level of care you genuinely need. Every figure below traces to a named primary or vendor source, not a vague “average.”
What an ADHD Evaluation Costs by Type
Evaluation pricing is driven almost entirely by depth. A primary-care screening is a short structured interview plus a rating scale; a full neuropsychological battery can consume 20 to 30 clinician hours across scoring, interpretation, and a written report. Those are different products, and the market prices them accordingly.
The table below reflects national cash-pay ranges compiled from provider-published pricing in late 2025 and early 2026. Period-specific and provider-specific figures vary, so treat these as planning ranges rather than quotes.
Source: Compiled from provider-published cash-pay pricing, 2025–2026 (verify current rates directly with each provider; period-specific data was unavailable as a single primary dataset).
Most adults land in the $400–$800 clinical band. The four-figure batteries earn their price only when the diagnostic picture is genuinely tangled — a suspected learning disability, a possible brain injury, or formal documentation for academic accommodations. Paying for neuropsychological testing when a clinical interview would suffice is the single most expensive avoidable error in this entire process. If you’re weighing which clinician type fits your situation, our breakdown of psychiatrist versus therapist roles and costs maps the tradeoffs.
How Insurance Reshapes the Evaluation Bill
Sticker price and out-of-pocket price are rarely the same number. Many plans cover a diagnostic evaluation as a medically necessary specialist visit, which can collapse an $800 cash quote down to a specialist copay. The catch: coverage for comprehensive psychological or neuropsychological testing is far less reliable and frequently requires documented medical necessity and preauthorization.
Consider a concrete scenario. A 34-year-old with a mid-tier commercial plan pays a $50 specialist copay for a covered clinical evaluation — versus $650 cash at the same practice. But when the clinician recommends full neuropsychological testing, the plan denies it as not medically necessary. Now the patient faces the entire $3,000 battery out of pocket, or an appeal. That denial-to-appeal path is common enough that understanding mental health parity law and benefit appeals can be worth thousands.
Two variables move your effective cost the most: whether the provider is in-network, and whether you’ve met your deductible. On a high-deductible plan early in the year, “covered” still means you pay the full negotiated rate until the deductible clears. The gap between in-network and out-of-network costs routinely exceeds several hundred dollars for the same appointment.
ADHD Medication Costs: Generic vs. Brand
Medication is where savvy shopping pays off fastest. The active-ingredient generics cost a fraction of their brand equivalents, and pharmacy discount cards push them lower still. GoodRx pricing, last updated in July 2026, illustrates the spread across the three most common stimulants.
Source: GoodRx retail and coupon pricing, most common version, updated July 2026 (GoodRx.com).
Brand Vyvanse at a $309.44 retail average versus its generic coupon price near $60.98 is a $248 monthly swing for a pharmacologically comparable product. Generic amphetamine salt combo at $16.99 with a coupon is cheaper than many insurance copays, which is why checking a discount card against your copay before every fill is worth the two minutes. One structural warning: stimulants are Schedule II controlled substances, and the CDC found 71.5% of adults taking stimulant ADHD medication had difficulty filling a prescription because it was unavailable. Price is only half the equation; supply is the other. The recurring visit tied to these prescriptions is its own line item — see our detail on medication management visit and prescription costs.
Therapy and Behavioral Treatment Pricing
Medication treats symptoms; behavioral therapy builds the skills that medication doesn’t. For adult ADHD, cognitive behavioral therapy adapted for executive-function challenges is the most evidence-backed talk therapy, and it carries standard psychotherapy pricing. Cash-pay sessions typically run $100–$250, with in-network insurance reducing that to a $20–$50 copay per visit.
ADHD coaching is a separate, non-clinical service — practical strategy work rather than diagnosis or treatment — running roughly $75–$200 per session and rarely covered by insurance. Neurofeedback, marketed heavily for ADHD, typically runs $50–$200 per session across 20 to 40 sessions, meaning a full course can exceed $2,000 with limited and inconsistent insurance reimbursement. Weigh that carefully against better-supported options. For a fuller picture of what different clinicians charge, our guide to therapy costs by provider type lays out the per-session math, and if budget is the constraint, low-cost sliding scale therapy can bring sessions down toward $20.
Because ADHD often travels with anxiety or depression, some patients alternate weekly therapy with less frequent prescriber check-ins. Comparing online therapy platform costs against local in-person rates helps you find the combination that fits both your schedule and your budget.
Cash-Pay Telehealth vs. Insurance-Based Psychiatry: Which Is Better for Ongoing ADHD Care?
Two dominant models compete for adults who need continuing medication management. Cash-pay ADHD telehealth trades insurance paperwork for speed and predictability: Done charges roughly $299 upfront plus $79 per month, and Klarity’s marketplace lists initial evaluations around $100–$150 with follow-ups near $59, no insurance accepted. Insurance-based psychiatry runs the opposite way: Talkiatry bills your plan like a specialist, with typical copays of $20–$60 per visit.
Run the first-year math. A Done member pays $299 plus twelve months at $79 — about $1,247 in platform fees before medication. A Talkiatry patient with a $40 copay attending an initial evaluation and monthly follow-ups pays roughly $520 in copays for the year, assuming the deductible is met. Cash-pay standalone visits without a subscription — evaluation plus quarterly maintenance check-ins — can land even lower for stable patients. The variable that decides it is your insurance: strong mental-health benefits favor the insurance model decisively, while thin or absent coverage narrows the gap.
Verdict
If you have functioning in-network mental-health benefits, insurance-based psychiatry like Talkiatry almost always wins on total annual cost, often by $700 or more versus a cash subscription. Choose cash-pay telehealth only when you lack coverage, need same-week access, or your plan’s psychiatry network is unusably thin. Whichever you pick, confirm the platform can legally prescribe stimulants in your state before paying anything — telehealth controlled-substance rules have tightened since 2023.
What Most People Get Wrong About ADHD Costs
Predictable, expensive mistakes cluster around a handful of decisions. Avoiding them is worth more than any single discount.
Over-buying the evaluation. Booking a $3,000 neuropsychological battery when a $600 clinical evaluation would produce the same diagnosis wastes thousands. The correct move: start with a standard clinical evaluation and escalate to testing only if the clinician identifies genuine diagnostic complexity.
Paying brand prices out of habit. Staying on brand Vyvanse at a $309.44 retail average when generic lisdexamfetamine runs about $60.98 with a coupon burns roughly $248 a month. Ask your prescriber to write for the generic and compare a discount card against your copay every fill.
Skipping the network check. Assuming a provider is in-network without verifying can turn a $50 copay into a full out-of-network charge. Confirm network status and deductible position before the first appointment, in writing.
Ignoring supply risk. With 71.5% of stimulant users reporting fill difficulties, treating medication as guaranteed leads to gaps. Line up a backup pharmacy and discuss alternatives with your prescriber before you run out.
Who Should Pay for Comprehensive Testing — and Who Shouldn’t?
The worth-it question turns on your specific situation, not on which option sounds most thorough. Comprehensive neuropsychological testing makes financial sense in narrow circumstances: when a learning disability may coexist with ADHD, when you need formal documentation for workplace or academic accommodations, or when multiple competing diagnoses must be differentiated. In those cases, the $2,500–$5,000+ outlay buys clarity that a shorter interview cannot.
For the majority of adults with reasonably clear-cut symptoms, it isn’t worth it. A standard clinical evaluation at $400–$800 delivers a valid diagnosis and a treatment plan, and the money saved covers months of medication and several therapy sessions. If cost is the binding constraint, university training clinics and Federally Qualified Health Centers offer sliding-scale evaluations that can drop far below cash-pay market rates.
Run the conditional logic: clear symptoms plus tight budget points to a clinical evaluation and generic medication; tangled diagnostic picture plus a need for documentation justifies testing; strong insurance plus a preference for physician-level care points to insurance-based psychiatry over cash subscriptions. Match the spend to the actual need, and the total drops sharply.
Frequently Asked Questions
Does insurance cover ADHD testing for adults?
Many plans cover a diagnostic evaluation as a medically necessary specialist visit, often reducing an $800 cash quote to a specialist copay. Coverage for comprehensive psychological or neuropsychological testing is far less reliable and frequently requires documented medical necessity and preauthorization. Testing requested solely for school placement is commonly excluded. Verify network status and preauthorization requirements with your plan before booking.
What’s the cheapest way to get ADHD medication?
Generic stimulants with a pharmacy discount card are cheapest. GoodRx lists generic Adderall (amphetamine salt combo) as low as $16.99 versus a $53.16 retail average, and generic Adderall XR near $27.54 against a $228.29 retail average, as of July 2026. Compare the coupon price against your insurance copay before every fill, since the discount card is sometimes lower than the copay.
Is cash-pay telehealth or insurance psychiatry cheaper for ADHD?
For insured patients, insurance-based psychiatry usually wins. Talkiatry copays of $20–$60 per visit can total around $520 a year, while a Done subscription at $299 upfront plus $79 monthly runs about $1,247 in platform fees before medication. Cash-pay makes sense mainly when you lack coverage, need same-week access, or your plan’s psychiatry network is too thin to use.
How We Researched This Article
This analysis draws on primary government data, vendor pharmacy pricing, and published provider rates, cross-checked against multiple sources for every figure. Adult ADHD prevalence, age-of-diagnosis, and prescription-fill difficulty statistics come directly from the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report published October 10, 2024 (CDC MMWR), which reported 15.5 million U.S. adults with a current diagnosis and a 71.5% fill-difficulty rate among stimulant users. Medication retail and coupon prices were taken from GoodRx pricing pages last updated in July 2026, reflecting the most common version of each drug at typical therapeutic doses.
Evaluation and therapy ranges were compiled from provider-published cash-pay pricing across multiple 2025–2026 sources and presented as defensible ranges because no single primary dataset aggregates national ADHD-specific evaluation prices; these are modeled planning ranges, not measured national averages. Telehealth platform pricing reflects published rates from Done, Klarity, and Talkiatry current as of early 2026 and is subject to change. Additional context on prevalence and provider mix draws on the National Center for Health Statistics Rapid Surveys System. Where sources disagreed on evaluation cost bands, we reported the consensus range rather than a single point figure. The first-year cost comparisons for telehealth versus insurance are modeled illustrations using stated platform fees and representative copays, not measured billing data, and assume the annual deductible has been met. Research was last conducted July 2026. All figures were verified against named primary sources before publication.